Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 25, 2026

Earnings live: Circle stock soars, First Solar and Lowe's fall on guidance misses

View original at finance.yahoo.com
Earnings live: Circle stock soars, First Solar and Lowe's fall on guidance misses Fourth quarter earnings season is entering its final stretch…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Domino's share on DoorDash expected to grow as awareness and marketing spend increases, representing meaningful opportunity as fair share not yet reached on major aggregators

    80% confidence
  • Adding approximately 1.1 million net new members in 2025 highlights incredible demand for the brand after 50% price increase

    80% confidence
  • Early reaction with shares down low-single digits makes sense with results and guidance in-line to slightly below expectations

    80% confidence
  • Growth journey continued into 2025 with commissioning of Louisiana factory and decision to establish South Carolina facility while maintaining disciplined approach to contracting and pricing certainty

    80% confidence
  • While housing macro remains pressured, company is focused on productivity initiatives and well-positioned to take share regardless of macro environment

    80% confidence
  • MORE strategy delivered higher sales and profits, showcasing ability to drive store level profitability while providing incredible value for customers

    80% confidence
  • Q4 results were largely in-line with expectations, reflecting lack of storm activity and ongoing consumer uncertainty in housing, with underlying demand relatively stable throughout the year when adjusting for storms

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com